Baupost Group LLC/ma

Seth Klarman, Baupost Group. 10% owner at Orexigen Therapeutics, Inc.; 10% owner at FACET BIOTECH CORP

Sold, on record
$13.4M
Dollars the filings state
Form 4 sales
3
Latest Oct 31, 2018
Form 144 notices
0
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale FACET BIOTECH CORPPlan not stated
    Sep 4, 2009 2009

    Sold 867,532 shares at $15.42 ($13.4M)

    Baupost Group LLC/ma, 10% owner

    Seth KlarmanSold 19.8% of holdings ($67.5M position)3.5M shares leftFirst sale on recordFiling

  2. 2 Form 4 sale Orexigen Therapeutics, Inc.Unusual
    Oct 25, 2018 +3338 days

    Sold 680,500 shares at $0.0100 ($7k)

    Baupost Group LLC/ma, 10% owner

    Seth KlarmanSold 30.6% of holdings ($22k position)1.5M shares leftFirst sale on recordFiling

  3. 3 Form 4 sale Orexigen Therapeutics, Inc.Unusual
    Oct 31, 2018 +6 days

    Sold 1.5M shares at $0.0100 ($15k)

    Baupost Group LLC/ma, 10% owner

    Seth KlarmanSold 100% of holdings ($15k position)0 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (3)

Form 144 notices and Form 4 sales by Baupost Group LLC/ma
Source
Oct 31, 2018Oct 31, 2018Orexigen Therapeutics, Inc.10% ownerForm 4 sale1.5M$15k100.0%UnusualSEC
Oct 25, 2018Oct 26, 2018Orexigen Therapeutics, Inc.10% ownerForm 4 sale680,500$7k30.6%UnusualSEC
Sep 4, 2009Sep 8, 2009FACET BIOTECH CORP10% ownerForm 4 sale867,532$13.4M19.8%Plan not statedSEC